MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.94%
After-hours: Aug 15, 2025, 07:59 PM EDT
MIRA Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 8.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -8.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.81M | -2.44M | -2.08M | -1.73M | -1.77M | -3.06M | -3.16M | -970.22K | -1.34M | -1.35M | -1.81M | -2.42M | -1.47M | -52.05K |
Interest Income | 21.42K | n/a | n/a | 39.4K | 50.42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.92K |
Pretax Income | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M | -1.34M | -1.35M | -1.81M | -2.42M | -1.48M | -56.98K |
Net Income | -1.78M | -2.4M | -2.04M | -1.69M | -1.72M | -5.79M | -3.59M | -1.27M | -1.34M | -1.35M | -1.81M | -2.42M | -1.48M | -56.98K |
Selling & General & Admin | 1.49M | 1.58M | 1.01M | 1.12M | 1.01M | 2.67M | 2.14M | 1.07M | 614.24K | 51.66K | 736.06K | 1.59M | 617.23K | 18.35K |
Research & Development | 314.4K | 861.44K | 1.07M | 614.46K | 762.28K | 387.12K | 1.02M | -101.02K | 271.61K | 884.76K | 714.97K | 269.39K | 479.05K | 33.71K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 453.55K | n/a | n/a | -453.55K | n/a | n/a | -560.8K | -374.9K | n/a |
Operating Expenses | 1.81M | 2.44M | 2.08M | 1.73M | 1.77M | 3.06M | 3.16M | 970.22K | 1.34M | 1.35M | 1.81M | 2.42M | 1.47M | 52.05K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 2.73M | 427.73K | 295.89K | 1.65K | 1.77K | 2.31K | 2.31K | 3.86K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.81M | 2.44M | 2.08M | 1.73M | 1.77M | 3.06M | 3.16M | 970.22K | 1.34M | 1.35M | 1.81M | 2.42M | 1.47M | 52.05K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -3.06K | -3.16K | -970.22 | -1.34K | -1.35K | -1.81K | -2.42K | n/a | n/a |
Shares Outstanding (Basic) | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M |
Shares Outstanding (Diluted) | 16.65M | 15.44M | 15.07M | 14.78M | 19.71M | 14.78M | 14.78M | 14.78M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M | 14.75M |
EPS (Basic) | -0.11 | -0.16 | -0.14 | -0.11 | -0.09 | -0.39 | -0.24 | -0.09 | -0.09 | -0.09 | -0.12 | -0.16 | -0.1 | -0.00 |
EPS (Diluted) | -0.11 | -0.16 | -0.14 | -0.11 | -0.09 | -0.39 | -0.24 | -0.09 | -0.09 | -0.09 | -0.12 | -0.16 | -0.1 | -0.00 |
EBITDA | -1.81M | -2.44M | -2.08M | -1.73M | -1.77M | n/a | -3.16M | -970.22K | -1.34M | n/a | -1.81M | -2.42M | -1.47M | n/a |
EBIT | -1.81M | -2.44M | -2.08M | -1.73M | -1.77M | -3.06M | -3.16M | -970.22K | -1.34M | -1.35M | -1.81M | -2.42M | -1.47M | -52.05K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 3.06M | 3.16M | 970.22K | 1.34M | 1.35M | 1.81M | 2.42M | 1.47M | 52.05K |